Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.

MLA

McGowan, Eileen M., et al. “Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.” International Journal of Molecular Sciences, vol. 21, no. 19, Sept. 2020. EBSCOhost, https://doi.org/10.3390/ijms21197189.

APA

McGowan, E. M., Haddadi, N., Nassif, N. T., & Lin, Y. (2020). Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19. International Journal of Molecular Sciences, 21(19). https://doi.org/10.3390/ijms21197189

Chicago

McGowan, Eileen M, Nahal Haddadi, Najah T Nassif, and Yiguang Lin. 2020. “Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.” International Journal of Molecular Sciences 21 (19). doi:10.3390/ijms21197189.